Literature DB >> 10688900

The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.

C Caslini1, A Shilatifard, L Yang, J L Hess.   

Abstract

Several lines of evidence suggest that the mixed lineage leukemia protein (MLL, ALL-1, HRX) plays a role in regulating myelomonocytic differentiation. In this study we examined the effect of expression of MLL-AF9 on differentiation of the monoblastic U937 cell line by using a tetracycline-inducible expression system. MLL-AF9 arrested growth of U937 cells and induced these cells to differentiate into macrophages; induction was accompanied by expression of CD11b and CD14 and ultimately cell death. Deletion mutants of MLL-AF9 were used to map the sequences responsible for this effect. The amino-terminal half of MLL was sufficient for both cell cycle arrest and macrophage differentiation, whereas the carboxyl terminus of MLL or AF9 was found to be dispensable for this effect. Further deletions showed that a 35-kDa amino-terminal fragment spanning two AT hook motifs was sufficient for cell cycle arrest, up-regulation of p21(Cip1) and p27(Kip1), and partial differentiation toward macrophages. These findings suggest a possible role for the MLL AT hook-containing region in regulating myelomonocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688900      PMCID: PMC16009          DOI: 10.1073/pnas.040574897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

Authors:  C Lavau; S J Szilvassy; R Slany; M L Cleary
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

2.  A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.

Authors:  S H Cross; R R Meehan; X Nan; A Bird
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

3.  Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein.

Authors:  T Yano; T Nakamura; J Blechman; C Sorio; C V Dang; B Geiger; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 4.  High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

Authors:  M Bustin; R Reeves
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1996

Review 5.  Disruption of a homolog of trithorax by 11q23 translocations: leukemogenic and transcriptional implications.

Authors:  P M Waring; M L Cleary
Journal:  Curr Top Microbiol Immunol       Date:  1997       Impact factor: 4.291

6.  Defects in yolk sac hematopoiesis in Mll-null embryos.

Authors:  J L Hess; B D Yu; B Li; R Hanson; S J Korsmeyer
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

7.  The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.

Authors:  R K Slany; C Lavau; M L Cleary
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

Review 8.  Chromosomal translocations in benign tumors: the HMGI proteins.

Authors:  J L Hess
Journal:  Am J Clin Pathol       Date:  1998-03       Impact factor: 2.493

9.  HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A.

Authors:  H T Adler; F S Nallaseth; G Walter; D C Tkachuk
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

10.  Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice.

Authors:  H Yagi; K Deguchi; A Aono; Y Tani; T Kishimoto; T Komori
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

View more
  15 in total

1.  mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.

Authors:  Blaine W Robinson; Giuseppe Germano; Yuanquan Song; Joshua Abrams; Marion Scott; Ilaria Guariento; Natascia Tiso; Francesco Argenton; Giuseppe Basso; Jennifer Rhodes; John P Kanki; A Thomas Look; Rita J Balice-Gordon; Carolyn A Felix
Journal:  Br J Haematol       Date:  2010-12-14       Impact factor: 6.998

2.  Effects of STI571 and p27 gene clone on proliferation and apoptosis of K562 cells.

Authors:  Wei Wang; Li-Bo Yao; Xin-Ping Liu; Qi Feng; Zhen-Chuan Shang; Yun-Xin Cao; Bing-Zhong Sun
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 3.  Chromosomal translocations involving the MLL gene: molecular mechanisms.

Authors:  Peter D Aplan
Journal:  DNA Repair (Amst)       Date:  2006-06-21

4.  Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.

Authors:  James J-D Hsieh; Patricia Ernst; Hediye Erdjument-Bromage; Paul Tempst; Stanley J Korsmeyer
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

5.  The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds.

Authors:  C Caslini; A S Alarcòn; J L Hess; R Tanaka; K G Murti; A Biondi
Journal:  Leukemia       Date:  2000-11       Impact factor: 11.528

Review 6.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

7.  A Theileria annulata DNA binding protein localized to the host cell nucleus alters the phenotype of a bovine macrophage cell line.

Authors:  Brian R Shiels; Sue McKellar; Frank Katzer; Kim Lyons; Jane Kinnaird; Chris Ward; Jonathan M Wastling; David Swan
Journal:  Eukaryot Cell       Date:  2004-04

8.  Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4.

Authors:  Han Liu; Todd D Westergard; Amanda Cashen; David R Piwnica-Worms; Lori Kunkle; Ravi Vij; Can G Pham; John DiPersio; Emily H Cheng; James J Hsieh
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

9.  MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription.

Authors:  Corrado Caslini; James A Connelly; Amparo Serna; Dominique Broccoli; Jay L Hess
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

10.  Tetracycline regulator expression alters the transcriptional program of mammalian cells.

Authors:  Hubert Hackl; Anna Rommer; Torsten A Konrad; Christine Nassimbeni; Rotraud Wieser
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.